Skilled Immigration and Firm-Level Innovation: The U.S. H-1B Lottery

Working Papers

The growth of the global technology industry drives the migration of skilled labor towards countries like the United States that can utilize it, but the U.S. limits the immigration of skilled workers that are employed domestically by U.S. firms. Proponents argue skilled immigration allows firms to access technical skills that unavailable domestically and promote innovation, but there is little evidence of whether this firm-level effect exists.Read More

Closer Workers, More Productive Workers? 

Working Papers

A worker’s commuting distance to the workplace may have implications for her productivity through channels such as costly travel time and reduced knowledge spillovers, and these costs may drive observed agglomerative spatial patterns previously identi fied in the literature.Read More

Organizational Decision-Making and Information: Angel Investments by Venture Capital Partners

Working Papers

We study information aggregation in organizational decision-making for the financing of entrepreneurial ventures. We introduce a formal model of voting where agents face costly tacit information to improve their decision quality.Read More

Social Is the New Financial: How Startup Social Media Activity Influences Funding Outcomes

Working Papers

In this project, we explore the impact of startup firms’ social media activities on their entrepreneurial financing performance. Social media can mitigate information problems in entrepreneurial financing in two ways.Read More

A Typology of R&D Processes Based on Market Excludability and Information Appropriability 

Working Papers

We explore the relationship between competition among downstream commercializing firms (e.g. incumbent pharmaceutical firms) and upstream innovative firms (e.g. startup biotechnology firms). We find that in an alliance regime, common in high technology industries, competition among the commercializing firms can reduce the productivity of the innovators, resulting in a net loss of societal welfare (e.g. less drugs invented and brought to market). Read More

R&D Production Team Composition and Firm-Level Innovation

Working Papers

How should a firm organize the diversity of technical experience contained within its pool of inventive human capital when firm-level innovation is a desired performance outcome? Using a sample of biotechnology start-ups observed from their founding onwards we examine the implications of alternate firm-level design regimes.Read More

Origins and Outcomes of Entrepreneurs’ Network Ties

Published Research

This research explores the relationship between incumbent pharmaceutical firms and biotechnology startups. Skilled incumbents are more likely to bring a drug to market, market the drug well, etc., and add value to the startup and increase its chance of a successful exit (IPO or M&A event).Read More